Atlas Trials

Ventilator-associated Bacterial Pneumonia

12 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Ventilator-associated Bacterial Pneumonia

RecordFirmDate
Study to Evaluate the Efficacy and Safety of Intravenous Sulbactam-ETX2514 in the Treatment of Patients With Infections Caused by Acinetobacter Baumannii-calcoaceticus Complex (NCT03894046)Entasis Therapeutics2019-09-05
Oropharyngeal Aspiration to Reduce Ventilator-Related Pneumonia (NCT04107363)Ayşe AKBIYIK2015-07-01
Telavancin Observational Use Registry (TOUR) (NCT02288234)Cumberland Pharmaceuticals2014-11-01
Efficacy, Safety, Tolerability of Vabomere Compared to Best Available Therapy in Treating Serious Infections in Adults (NCT02168946)Rempex (a wholly owned subsidiary of Melinta Therapeutics, Inc.)2014-07-01
Study of Cases of Serious Infections Due to Carbapenem-Resistant Enterobacteriaceae (NCT02420366)Rempex (a wholly owned subsidiary of Melinta Therapeutics, Inc.)2014-05-01
The Effect of Ulinastatin on Bronchoalveolar Lavage Fluid of Inflammatory Factors in Patients With Ventilator-associated Pneumonia (NCT01865266)Shanghai Minhang Central Hospital2014-01-01
Trial of Colistin Versus Meropenem in Ventilator-associated Pneumonia (VAP) (CR-GNB) (NCT01292031)Fundación Pública Andaluza para la gestión de la Investigación en Sevilla2012-05-01

Track Ventilator-associated Bacterial Pneumonia automatically

Every clearance here is in the API, with alerts when new ones post.